Skip to main content

Table 3 Outcomes for Thoracic Endovascular Aortic Repair with Unrevascularized and Revascularized left subclavian artery, Carotid-Subclavian Bypass, and F-TEVAR

From: Left subclavian artery revascularization in thoracic endovascular aortic repair: single center’s clinical experiences from 171 patients

Variables

Overall

Unrevascularized (n = 28)

Revascularized (n = 143)

P1 value

iP2 value

CSB (n = 100)

F-TEVAR (n = 43)

30-day outcomes, n

171

28

100

43

  

 Mortality (N, %)

1, 0.6%

1, 3.6%

0, 0%

0, 0%

0.164

_

 Stroke (N, %)

2, 1.2%

0, 0%

2, 2.0%

0, 0%

1

1

 Left upper extremity ischemia (N, %)

2, 1.2%

0, 0%

2, 2%

0, 0%

1

1

 Spinal cord ischemia (N, %)

5, 2.9%

3, 10.7%

1, 1.0%

1, 2.3%

0.032*

0.512

Midterm outcomes, n

167

26

100

41

  

 Mortality (N, %)

10, 6.0%

2, 7.7%

8, 8%

0, 0%

1

0.143

 Stroke (N, %)

9, 5.4%

3, 11.5%

4, 4.0%

2, 4.9%

0.299

1

 Left upper extremity ischemia (N, %)

12, 7.2%

4, 15.4%

6, 6.0%

2, 4.9%

0.177

1

 Spinal cord ischemia (N, %)

0, 0%

0, 0%

0, 0%

0, 0%

_

_

  1. P1 value, unrevascularied versus revascularized
  2. P2 value, CSB versus F-TEVAR
  3. *Statistically significant values